Bupivacaine blocks N-type inactivating Kv channels in the open state: no allosteric effect on inactivation kinetics.
Local anesthetics bind to ion channels in a state-dependent manner. For noninactivating voltage-gated K channels the binding mainly occurs in the open state, while for voltage-gated inactivating Na channels it is assumed to occur mainly in inactivated states, leading to an allosterically caused increase in the inactivation probability, reflected in a negative shift of the steady-state inactivation curve, prolonged recovery from inactivation, and a frequency-dependent block. How local anesthetics bind to N-type inactivating K channels is less explored. In this study, we have compared bupivacaine effects on inactivating (Shaker and K(v)3.4) and noninactivating (Shaker-IR and K(v)3.2) channels, expressed in Xenopus oocytes. Bupivacaine was found to block these channels time-dependently without shifting the steady-state inactivation curve markedly, without a prolonged recovery from inactivation, and without a frequency-dependent block. An analysis, including computational testing of kinetic models, suggests binding to the channel mainly in the open state, with affinities close to those estimated for corresponding noninactivating channels (300 and 280 microM for Shaker and Shaker-IR, and 60 and 90 microM for K(v)3.4 and K(v)3.2). The similar magnitudes of K(d), as well as of blocking and unblocking rate constants for inactivating and noninactivating Shaker channels, most likely exclude allosteric interactions between the inactivation mechanism and the binding site. The relevance of these results for understanding the action of local anesthetics on Na channels is discussed.
Nilsson
Johanna
J
Department of Neuroscience, Nobel Institute for Neurophysiology, Karolinska Institutet, Stockholm, Sweden.
Madeja
Michael
M
Elinder
Fredrik
F
Arhem
Peter
P
D000494:Allosteric Regulation / Q000187:drug effects; D000818:Animals; D001665:Binding Sites; D002045:Bupivacaine / Q000494:pharmacology*; D015640:Ion Channel Gating / Q000187:drug effects*; D007700:Kinetics; D008958:Models, Molecular; D026902:Potassium Channel Blockers / Q000494:pharmacology*; D024642:Potassium Channels, Voltage-Gated / Q000378:metabolism*; D051670:Shaw Potassium Channels / Q000378:metabolism; D013997:Time Factors; D029867:Xenopus Proteins / Q000378:metabolism; D014982:Xenopus laevis / Q000378:metabolism
D026902:Potassium Channel Blockers; D024642:Potassium Channels, Voltage-Gated; D051670:Shaw Potassium Channels; D029867:Xenopus Proteins; D002045:Bupivacaine
Cell. 1987 Jul 31;50(3):405-13
2440582
Biophys J. 2000 Dec;79(6):3019-35
11106609
Mol Pharmacol. 2004 Nov;66(5):1103-12
15286210
Biophys J. 1984 Jul;46(1):15-27
6331543
Eur J Pharmacol. 1998 Oct 30;360(1):21-9
9845268
Neuropsychopharmacology. 2003 Jul;28 Suppl 1:S40-7
12827143
Nature. 2002 May 30;417(6888):523-6
12037560
FEBS Lett. 1988 Dec 19;242(1):199-206
2462513
Nature. 2001 Jun 7;411(6838):657-61
11395760
J Gen Physiol. 1987 Apr;89(4):645-67
2438374
Science. 1994 Sep 16;265(5179):1724-8
8085162
J Physiol. 2001 Dec 15;537(Pt 3):701-14
11744749
J Neurosci Methods. 1991 Jul;38(2-3):267-9
1784130
Science. 1987 Aug 14;237(4816):770-5
2441471
Biophys J. 1978 Aug;23(2):285-311
687766
Science. 1998 Apr 3;280(5360):69-77
9525859
J Pharmacol Exp Ther. 2001 Feb;296(2):573-83
11160646
J Gen Physiol. 2002 Jul;120(1):39-51
12084774
J Gen Physiol. 1983 May;81(5):613-42
6306139
Biochim Biophys Acta. 2003 Nov 3;1652(1):35-51
14580995
Mol Pharmacol. 2002 Nov;62(5):1228-37
12391287
Biophys J. 2001 Aug;81(2):895-904
11463633
Science. 2005 Aug 5;309(5736):897-903
16002581
J Gen Physiol. 1999 Jan;113(1):7-16
9874684
Mol Pharmacol. 2003 Jun;63(6):1417-29
12761353
J Membr Biol. 1998 Sep 15;165(2):183-9
9745006
Eur J Pharmacol. 1991 Sep 12;208(1):1-8
1936128
Biophys J. 2001 Apr;80(4):1802-9
11259293
Biophys J. 1990 Jul;58(1):53-68
2166601
Circ Res. 1995 Sep;77(3):584-92
7641328
J Gen Physiol. 2004 Dec;124(6):691-701
15545401
J Gen Physiol. 1977 Apr;69(4):497-515
300786
J Physiol. 2002 Jun 15;541(Pt 3):701-16
12068034
J Physiol. 1996 Oct 1;496 ( Pt 1):145-54
8910203
J Cardiovasc Electrophysiol. 1998 Jul;9(7):727-42
9684721
J Physiol. 2004 Feb 1;554(Pt 3):621-33
14608007
Biophys J. 1978 Nov;24(2):569-74
728531
J Gen Physiol. 1999 Jan;113(1):3-6
9874683
Mol Pharmacol. 2008 Mar;73(3):940-8
18079277
Anesthesiology. 1988 Feb;68(2):201-12
3341573
Nature. 2006 Mar 23;440(7083):463-9
16554806
Science. 1990 Oct 26;250(4980):568-71
2122520
Biochim Biophys Acta. 1977 Nov 14;472(3-4):373-98
334262
Anesthesiology. 2007 Oct;107(4):641-51
17893461
Br J Anaesth. 2004 Jan;92(1):93-101
14665560
J Physiol. 2004 Oct 1;560(Pt 1):37-49
15272045
J Gen Physiol. 1994 Feb;103(2):321-62
8189208
J Gen Physiol. 1994 Sep;104(3):523-39
7807060